View Item 

Show simple item record

Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells

dc.contributor.authorSim, Michael W.
dc.contributor.authorGrogan, Patrick T.
dc.contributor.authorSubramanian, Chitra
dc.contributor.authorBradford, Carol R.
dc.contributor.authorCarey, Thomas E.
dc.contributor.authorForrest, M. Laird
dc.contributor.authorPrince, Mark E.
dc.contributor.authorCohen, Mark S.
dc.date.accessioned2017-05-10T17:48:11Z
dc.date.available2017-07-10T14:31:43Zen
dc.date.issued2016-05
dc.identifier.citationSim, Michael W.; Grogan, Patrick T.; Subramanian, Chitra; Bradford, Carol R.; Carey, Thomas E.; Forrest, M. Laird; Prince, Mark E.; Cohen, Mark S. (2016). "Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells." The Laryngoscope 126(5): E184-E190.
dc.identifier.issn0023-852X
dc.identifier.issn1531-4995
dc.identifier.urihttps://hdl.handle.net/2027.42/136702
dc.publisherAmerican Cancer Society
dc.publisherWiley Periodicals, Inc.
dc.subject.otherLarynx cancer
dc.subject.othertargeted therapy
dc.subject.otherCD44
dc.subject.otherhyaluronan nanoconjugate
dc.subject.othercancer stem cells
dc.titleEffects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136702/1/lary25808_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136702/2/lary25808.pdf
dc.identifier.doi10.1002/lary.25808
dc.identifier.sourceThe Laryngoscope
dc.identifier.citedreferenceSanki A, Kam PC, Thompson JF. Long‐term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg 2007; 245: 591 – 596.
dc.identifier.citedreferenceKelland L. The resurgence of platinum‐based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573 – 584.
dc.identifier.citedreferenceChu G. Cellular responses to cisplatin. The roles of DNA‐binding proteins and DNA repair. J Biol Chem 1994; 269: 787 – 790.
dc.identifier.citedreferencePrince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 2008; 26: 2871 – 2875.
dc.identifier.citedreferenceKorkaya H, Wicha MS. Selective targeting of cancer stem cells: a new concept in cancer therapeutics. BioDrugs 2007; 21: 299 – 310.
dc.identifier.citedreferenceCai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. J Pharm Sci 2010; 99: 2664 – 2671.
dc.identifier.citedreferenceCohen SM, Rockefeller N, Mukerji R, et al. Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2013; 139: 382 – 387.
dc.identifier.citedreferenceWang SJ, Bourguignon LY. Role of hyaluronan‐mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 2011; 178: 956 – 963.
dc.identifier.citedreferencePrince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973 – 978.
dc.identifier.citedreferenceCai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan‐cisplatin conjugate. J Surg Res 2008; 147: 247 – 252.
dc.identifier.citedreferenceFeleszko W, Zagozdzon R, Golab J, Jakobisiak M. Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice. Eur J Cancer 1998; 34: 406 – 411.
dc.identifier.citedreferenceGraeser R, Esser N, Unger H, et al. INNO‐206, the (6‐maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model. Invest New Drugs 2010; 28: 14 – 19.
dc.identifier.citedreferenceSamadi AK, Zhang X, Mukerji R, Donnelly AC, Blagg BS, Cohen MS. A novel C‐terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells. Cancer Lett 2011; 312: 158 – 167.
dc.identifier.citedreferenceWicha Lab Manual, University of Michigan Comprehensive Cancer Center. Human tumor digestion (from primary tumor) to obtain single cell suspension. Available at: http://www.med.umich.edu/wicha‐lab/SOP/SOP%202.2‐%20Human%20Tumor%20Digestion.pdf. Accessed July 8, 2013.
dc.identifier.citedreferenceJacobs C, Lyman G, Velez‐Garcia E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257 – 263.
dc.identifier.citedreferenceNoda T, Ohigashi H, Ishikawa O, et al. Liver perfusion chemotherapy for selected patients at a high‐risk of liver metastasis after resection of duodenal and ampullary cancers. Ann Surg 2007; 246: 799 – 805.
dc.identifier.citedreferenceChandana SR, Conley BA. Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects. Curr Opin Oncol 2009; 21: 218 – 223.
dc.identifier.citedreferenceWorden FP, Moyer J, Lee JS, et al. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 2009; 119: 1510 – 1517.
dc.identifier.citedreferenceWong SY, Hynes RO. Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 2006; 5: 812 – 817.
dc.identifier.citedreferenceAl‐Hajj M, Clarke MF. Self‐renewal and solid tumor stem cells. Oncogene 2004; 23: 7274 – 7282.
dc.identifier.citedreferenceCho RW, Clarke MF. Recent advances in cancer stem cells. Curr Opin Genet Dev 2008; 18: 48 – 53.
dc.identifier.citedreferenceLobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Ann Rev Cell Dev Biol 2007; 23: 675 – 699.
dc.identifier.citedreferenceReya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105 – 111.
dc.identifier.citedreferenceWicha MS, Liu S, Dontu G. Cancer stem cells: an old idea—a paradigm shift. Cancer Res 2006; 66: 1883 – 1890; discussion 1895–1896.
dc.identifier.citedreferenceAl‐Assar O, Muschel RJ, Mantoni TS, McKenna WG, Brunner TB. Radiation response of cancer stem‐like cells from established human cell lines after sorting for surface markers. Int J Radiat Oncol Biol Phys 2009; 75: 1216 – 1225.
dc.identifier.citedreferenceBao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756 – 760.
dc.identifier.citedreferenceIschenko I, Seeliger H, Schaffer M, Jauch KW, Bruns CJ. Cancer stem cells: how can we target them? Curr Med Chem 2008; 15: 3171 – 3184.
dc.identifier.citedreferenceAmerican Cancer Society. Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 2014.
dc.identifier.citedreferenceForastiere AA. Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 2008; 97: 701 – 707.
dc.identifier.citedreferenceCai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Carrier‐based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck. Ther Deliv 2010; 1: 237 – 245.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
lary25808_am.pdf
Size:
1.956MB
Format:
PDF
View/Open
Name:
lary25808.pdf
Size:
410.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.